Air pollution and cardiovascular disease: Can the Australian bushfires and global COVID-19 pandemic of 2020 convince us to change our ways?

BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Kathryn WolhuterJason C Kovacic

Abstract

Air pollution is a major global challenge for a multitude of reasons. As a specific concern, there is now compelling evidence demonstrating a causal relationship between exposure to airborne pollutants and the onset of cardiovascular disease (CVD). As such, reducing air pollution as a means to decrease cardiovascular morbidity and mortality should be a global health priority. This review provides an overview of the cardiovascular effects of air pollution and uses two major events of 2020-the Australian bushfires and COVID-19 pandemic lockdown-to illustrate the relationship between air pollution and CVD. The bushfires highlight the substantial human and economic costs associated with elevations in air pollution. Conversely, the COVID-19-related lockdowns demonstrated that stringent measures are effective at reducing airborne pollutants, which in turn resulted in a potential reduction in cardiovascular events. Perhaps one positive to come out of 2020 will be the recognition that tough measures are effective at reducing air pollution and that these measures have the potential to stop thousands of deaths from CVD.

References

Mar 6, 1998·American Industrial Hygiene Association Journal·Y QianC C Coffey
Oct 28, 1999·American Heart Journal·C A PopeD W Dockery
Jan 1, 2000·Epidemiology·A PetersD W Dockery
Aug 12, 2000·Journal of the Air & Waste Management Association·R J KlemmD W Dockery
Dec 15, 2000·The New England Journal of Medicine·J M SametS L Zeger
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·A NemmarB Nemery
Sep 7, 2002·Stroke; a Journal of Cerebral Circulation·Yun-Chul HongHo-Jang Kwon
Apr 15, 2003·Inhalation Toxicology·Christopher C DaigleMark W Frampton
May 24, 2003·The European Respiratory Journal. Supplement·R B DevlinW Cascio
Aug 9, 2005·Mutation Research·Lotte RisomSteffen Loft
Jan 6, 2006·Environmental Health Perspectives·Bart OstroMichael Lipsett
Jan 18, 2006·JAMA : the Journal of the American Medical Association·Qinghua SunSanjay Rajagopalan
Jun 30, 2006·Journal of the Air & Waste Management Association·C Arden Pope, Douglas W Dockery
Apr 21, 2007·American Journal of Respiratory and Critical Care Medicine·Håkan TörnqvistAnders Blomberg
Aug 2, 2008·The New England Journal of Medicine·Jill P PellWilliam Borland
Aug 6, 2008·Environmental Health : a Global Access Science Source·Ivan C HaniganGeoffrey G Morgan
Oct 28, 2008·European Heart Journal·Andrew J LuckingDavid E Newby
Dec 20, 2008·Epidemiology·Mats RosenlundLars Alfredsson
Feb 24, 2009·Epidemiology·Lindsay J L ForbesRoss H Anderson
Mar 17, 2009·Particle and Fibre Toxicology·Jeremy P LangrishLixin Jiang
Apr 23, 2010·Journal of the American Society of Hypertension : JASH·Robert D Brook, Sanjay Rajagopalan
May 12, 2010·Circulation·Robert D BrookUNKNOWN American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Coun
Aug 10, 2010·American Journal of Respiratory Cell and Molecular Biology·Catherine A ShawPatrick W F Hadoke
Nov 23, 2010·Journal of the American College of Cardiology·Marcus BauerUNKNOWN HNR Study Investigative Group
Jul 2, 2011·Occupational and Environmental Medicine·Andrew J GhioAna Rappold
Apr 6, 2012·Epidemiology·Anna OudinKristina Jakobsson
May 1, 2012·European Journal of Preventive Cardiology·Annette PetersH Erich Wichmann
Aug 9, 2012·Future Cardiology·Mark R MillerJeremy P Langrish
Oct 11, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Alex P CarllAimen K Farraj
Sep 25, 2014·Journal of Hypertension·Ruijuan LiangZhongjie Fan
Mar 27, 2015·BMJ : British Medical Journal·Anoop S V ShahNicholas L Mills
May 12, 2015·Critical Reviews in Toxicology·Julie E GoodmanFerdinand J Venditti
Jul 17, 2015·Journal of the American Heart Association·Anjali HaikerwalMartine Dennekamp

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.